Global Neuroprotective Agents Market Share

Statistics for the 2023 & 2024 Global Neuroprotective Agents market share, created by Mordor Intelligence™ Industry Reports. Global Neuroprotective Agents share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Neuroprotective Agents Industry

The Neuroprotective Agents Market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Merck KGaA, Novartis Pharmaceuticals Corporation, Teva Pharmaceutical Industries Ltd., Genervon Biopharmaceuticals, LLC., Neuren Pharmaceuticals, Pfizer Inc, GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals PLC.

Neuroprotective Agents Market Leaders

  1. Merck KGaA

  2. Novartis Pharmaceuticals Corporation

  3. Teva Pharmaceutical Industries Ltd.

  4. Pfizer Inc

  5. GlaxoSmithKline plc.

*Disclaimer: Major Players sorted in no particular order

Merck KGaA, Novartis Pharmaceuticals Corporation, Teva Pharmaceutical Industries Ltd., Pfizer Inc, GlaxoSmithKline plc.

Neuroprotective Agents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)